Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,327 | 195 | 126 | 0 | 0 |
| Receivables | 408 | 112 | 27 | 0 | 0 |
| Inventories | 820 | 543 | 588 | 0 | 0 |
| Other current assets | 900 | 438 | 496 | 0 | 0 |
| TOTAL | $3,455 | $1,288 | $1,237 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 107 | 88 | 27 | N/A | N/A |
| Intangibles | 68 | 31 | 62 | 0 | 0 |
| Other Non-Current Assets | 1,247 | 82 | 112 | 0 | 0 |
| TOTAL | $1,423 | $200 | $201 | $N/A | $N/A |
| Total Assets | $4,878 | $1,488 | $1,439 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 692 | 608 | 307 | 0 | 0 |
| Accrued Expenses | 14 | 59 | 28 | 0 | 0 |
| Other current liabilities | 714 | 413 | 466 | 0 | 0 |
| TOTAL | $2,488 | $2,629 | $3,151 | $0 | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,094 | 2,211 | N/A | 0 | 0 |
| Deferred Revenues | 619 | N/A | N/A | N/A | N/A |
| TOTAL | $3,094 | $2,211 | $N/A | $N/A | $N/A |
| Total Liabilities | $5,582 | $4,840 | $3,151 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,916 | 1,697 | N/A | N/A | N/A |
| Common Shares | 96 | 85 | 83 | 0 | 0 |
| Retained earnings | -42,133 | -30,283 | -16,993 | 0 | 0 |
| TOTAL | $-704 | $-3,352 | $-1,712 | $0 | $0 |
| Total Liabilities And Equity | $4,878 | $1,488 | $1,439 | $0 | $0 |